Request Services

Zimmer Biomet announced today that Vafa Jamali will serve as the CEO of “NewCo,” the spine and dental business spinoff that Zimmer Biomet expects to close in mid-2022.

A more than 25-year medtech veteran, Jamali most recently served as chief commercial officer of Rockley Photonics. Before that, he was SVP and president of Respiratory, Gastrointestinal & Informatics (RGI) at Medtronic. Over the years, he’s also held leadership positions at Covidien, Cardinal Health, and Baxter.

“Vafa’s extensive knowledge and experience in building teams, developing long-term growth strategies, prioritizing resources, driving execution and delivering growth across the medical device industry make him the ideal leader to shape the direction of NewCo and move the business forward”
Bryan Hanson Zimmer Biomet CEO

Jamali touted his execution and value creation experience. “I am looking forward to working closely with the new team to develop and drive investment strategies and a plan for long-term growth in the Spine and Dental markets — all with a relentless focus on delivering for patients, customers, team members and our future shareholders,” he said.

The businesses that fall under the NewCo banner made up nearly 13% of Zimmer Biomet revenues over the past two years, bringing in $1.022 billion in 2019 and $897 million in 2020. Differentiated spine products to help power NewCo’s growth include the Rosa One Spine robotic surgery system, the Mobi-C cervical disc and The Tether. Dental boasts a whole suite of oral reconstruction products.

This article was originally published by Mass Device and can be viewed here